167 related articles for article (PubMed ID: 23094127)
1. Pelvic exenteration for recurrent cervical cancer: ten-year experience at National Cancer Center in Korea.
Yoo HJ; Lim MC; Seo SS; Kang S; Yoo CW; Kim JY; Park SY
J Gynecol Oncol; 2012 Oct; 23(4):242-50. PubMed ID: 23094127
[TBL] [Abstract][Full Text] [Related]
2. Retrospective study of combined pelvic exenteration in the treatment of primary and recurrent pelvic malignant tumors.
Li C; Li Z; Zhang J; Zhang X; Siesto G; Li S; Ma P; Zhang J; Li Z; Zhao Y
J Gastrointest Oncol; 2024 Feb; 15(1):299-311. PubMed ID: 38482226
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy prior to pelvic exenteration in patients with recurrent cervical cancer: single institution experience.
Landoni F; Zanagnolo V; Rosenberg PG; Lopes A; Radice D; Bocciolone L; Aletti G; Parma G; Colombo N; Maggioni A
Gynecol Oncol; 2013 Jul; 130(1):69-74. PubMed ID: 23474343
[TBL] [Abstract][Full Text] [Related]
4. Indications for primary and secondary exenterations in patients with cervical cancer.
Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
[TBL] [Abstract][Full Text] [Related]
5. Total pelvic exenteration for primary and recurrent malignancies.
Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
[TBL] [Abstract][Full Text] [Related]
6. Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan.
Maggioni A; Roviglione G; Landoni F; Zanagnolo V; Peiretti M; Colombo N; Bocciolone L; Biffi R; Minig L; Morrow CP
Gynecol Oncol; 2009 Jul; 114(1):64-8. PubMed ID: 19411097
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of pelvic exenterations for gynecological malignancies: a single-center retrospective cohort study.
Yu JH; Tong CJ; Huang QD; Ye YL; Chen G; Li H; Wen YS; Yang F; Luo NB; Xu GY; Xiong Y
BMC Cancer; 2024 Jan; 24(1):88. PubMed ID: 38229045
[TBL] [Abstract][Full Text] [Related]
8. Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients.
Chiantera V; Rossi M; De Iaco P; Koehler C; Marnitz S; Ferrandina G; Legge F; Parazzini F; Scambia G; Schneider A; Vercellino GF
Int J Gynecol Cancer; 2014 Jun; 24(5):916-22. PubMed ID: 24442006
[TBL] [Abstract][Full Text] [Related]
9. [Outcomes of perisurgery and short-time follow-up of pelvic exenteration for 17 cases with locally recurrent cervical cancer].
Deng H; Wang JL; Wang ZQ; Li XW; Hu H; Yang B; Zhang XM; Shen K; Guo P; Liang B
Zhonghua Fu Chan Ke Za Zhi; 2020 Apr; 55(4):259-265. PubMed ID: 32375433
[No Abstract] [Full Text] [Related]
10. Pelvic Exenteration in Advanced Gynecologic Malignancies - Who Will Benefit?
Egger EK; Liesenfeld H; Stope MB; Recker F; Döser A; Könsgen D; Marinova M; Hilbert T; Exner D; Ellinger J; Mustea A
Anticancer Res; 2021 Jun; 41(6):3037-3043. PubMed ID: 34083295
[TBL] [Abstract][Full Text] [Related]
11. [Current status and outcomes of pelvic exenteration for recurrent cervical cancer: a systematic review].
Chen M; Pan L
Zhonghua Fu Chan Ke Za Zhi; 2014 Jun; 49(6):460-5. PubMed ID: 25169641
[TBL] [Abstract][Full Text] [Related]
12. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
[No Abstract] [Full Text] [Related]
13. Major complications following exenteration in cases of pelvic malignancy: a 10-year experience.
Wydra D; Emerich J; Sawicki S; Ciach K; Marciniak A
World J Gastroenterol; 2006 Feb; 12(7):1115-9. PubMed ID: 16534855
[TBL] [Abstract][Full Text] [Related]
14. Pelvic exenteration for recurrent gynecologic malignancy: a study of 28 consecutive patients at a single institution.
Jäger L; Nilsson PJ; Rådestad AF
Int J Gynecol Cancer; 2013 May; 23(4):755-62. PubMed ID: 23407096
[TBL] [Abstract][Full Text] [Related]
15. Pelvic exenterations for gynecological malignancies: a study of 36 cases.
Kaur M; Joniau S; D'Hoore A; Van Calster B; Van Limbergen E; Leunen K; Penninckx F; Van Poppel H; Amant F; Vergote I
Int J Gynecol Cancer; 2012 Jun; 22(5):889-96. PubMed ID: 22617477
[TBL] [Abstract][Full Text] [Related]
16. Salvage Surgery for Cervical Cancer Recurrences.
Rema P; Mathew AP; Suchetha S; Ahmed I
Indian J Surg Oncol; 2017 Jun; 8(2):146-149. PubMed ID: 28546709
[TBL] [Abstract][Full Text] [Related]
17. Pelvic Exenteration for Recurrent and Persistent Cervical Cancer.
Li L; Ma SQ; Tan XJ; Zhong S; Wu M
Chin Med J (Engl); 2018 Jul; 131(13):1541-1548. PubMed ID: 29941707
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic pelvic exenteration and laterally extended endopelvic resection for postradiation recurrent cervical carcinoma: Technical feasibility and short-term oncologic outcome.
Kanao H; Aoki Y; Omi M; Nomura H; Tanigawa T; Okamoto S; Chang EJ; Kurita T; Netsu S; Matoda M; Omatsu K; Matsuo K
Gynecol Oncol; 2021 Apr; 161(1):34-38. PubMed ID: 33423805
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome of pelvic exenteration in patients with advanced or recurrent uterine cervical cancer.
Tanaka S; Nagase S; Kaiho-Sakuma M; Nagai T; Kurosawa H; Toyoshima M; Tokunaga H; Otsuki T; Utsunomiya H; Takano T; Niikura H; Ito K; Yaegashi N
Int J Clin Oncol; 2014 Feb; 19(1):133-8. PubMed ID: 23404487
[TBL] [Abstract][Full Text] [Related]
20. Gynecologic Oncology: Pelvic Exenteration for Advanced or Recurring Cervical Cancer - A Single Center Analysis.
Glane LT; Hegele A; Wagner U; Boekhoff J
Cancer Diagn Progn; 2022; 2(3):308-315. PubMed ID: 35530642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
